These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33179471)

  • 1. Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project.
    Sargas C; Ayala R; Chillón MC; Larráyoz MJ; Carrillo-Cruz E; Bilbao C; Yébenes-Ramírez M; Llop M; Rapado I; García-Sanz R; Vázquez I; Soria E; Florido-Ortega Y; Janusz K; Botella C; Serrano J; Martínez-Cuadrón D; Bergua J; Amigo ML; Martínez-Sánchez P; Tormo M; Bernal T; Herrera-Puente P; García R; Algarra L; Sayas MJ; Costilla-Barriga L; Pérez-Santolalla E; Marchante I; Lavilla-Rubira E; Noriega V; Alonso-Domínguez JM; Sanz MÁ; Sánchez-Garcia J; Gómez-Casares MT; Pérez-Simón JA; Calasanz MJ; González-Díaz M; Martínez-López J; Barragán E; Montesinos P
    Haematologica; 2021 Dec; 106(12):3079-3089. PubMed ID: 33179471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
    Sargas C; Ayala R; Larráyoz MJ; Chillón MC; Carrillo-Cruz E; Bilbao-Sieyro C; Prados de la Torre E; Martínez-Cuadrón D; Rodríguez-Veiga R; Boluda B; Gil C; Bernal T; Bergua JM; Algarra L; Tormo M; Martínez-Sánchez P; Soria E; Serrano J; Alonso-Domínguez JM; García-Boyero R; Amigo ML; Herrera-Puente P; Sayas MJ; Lavilla-Rubira E; Martínez-López J; Calasanz MJ; García-Sanz R; Pérez-Simón JA; Gómez-Casares MT; Sánchez-García J; Barragán E; Montesinos P; On Behalf Of Pethema Group
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience.
    Steidl C; Aroldi A; Mologni L; Crespiatico I; Fontana D; Mastini C; Fumagalli M; Perfetti P; Borin L; Valentini C; Piazza R; Gambacorti-Passerini C
    Leuk Res; 2022 Jul; 118():106861. PubMed ID: 35653850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
    Kohlmann A; Bacher U; Schnittger S; Haferlach T
    Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in gene mutation profile in patients with refractory/relapsed versus newly diagnosed acute myeloid leukemia based on targeted next-generation sequencing.
    Wang M; Wang R; Wang H; Chen C; Qin J; Gao X; Yu L
    Leuk Lymphoma; 2021 Oct; 62(10):2416-2427. PubMed ID: 33913388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
    Rosenthal SH; Gerasimova A; Ma C; Li HR; Grupe A; Chong H; Acab A; Smolgovsky A; Owen R; Elzinga C; Chen R; Sugganth D; Freitas T; Graham J; Champion K; Bhattacharya A; Racke F; Lacbawan F
    PLoS One; 2021; 16(4):e0243683. PubMed ID: 33909614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-Laboratory Evaluation of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia.
    Haslam K; Catherwood MA; Dobbin E; Sproul A; Langabeer SE; Mills KI
    Mol Diagn Ther; 2016 Oct; 20(5):457-61. PubMed ID: 27342108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse.
    Press RD; Eickelberg G; Froman A; Yang F; Stentz A; Flatley EM; Fan G; Lim JY; Meyers G; Maziarz RT; Cook RJ
    Am J Hematol; 2019 Aug; 94(8):902-912. PubMed ID: 31124175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring.
    Luthra R; Patel KP; Reddy NG; Haghshenas V; Routbort MJ; Harmon MA; Barkoh BA; Kanagal-Shamanna R; Ravandi F; Cortes JE; Kantarjian HM; Medeiros LJ; Singh RR
    Haematologica; 2014 Mar; 99(3):465-73. PubMed ID: 24142997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing.
    Balagopal V; Hantel A; Kadri S; Steinhardt G; Zhen CJ; Kang W; Wanjari P; Ritterhouse LL; Stock W; Segal JP
    PLoS One; 2019; 14(10):e0224097. PubMed ID: 31658273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia.
    Flach J; Shumilov E; Wiedemann G; Porret N; Shakhanova I; Bürki S; Legros M; Joncourt R; Pabst T; Bacher U
    Hematol Oncol; 2020 Oct; 38(4):425-431. PubMed ID: 32306411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome-excess blasts detected by next-generation sequencing technique.
    Owattanapanich W; Herzig J; Jahn N; Panina E; Ruchutrakool T; Kungwankiattichai S; Issaragrisil S; Döhner H; Döhner K
    Ann Hematol; 2021 Aug; 100(8):1983-1993. PubMed ID: 33839881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse.
    Kim T; Moon JH; Ahn JS; Kim YK; Lee SS; Ahn SY; Jung SH; Yang DH; Lee JJ; Choi SH; Lee JY; Tyndel MS; Shin MG; Lee YJ; Sohn SK; Park SK; Zhang Z; Kim HJ; Kim DDH
    Blood; 2018 Oct; 132(15):1604-1613. PubMed ID: 30108064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
    Yang F; Anekpuritanang T; Press RD
    Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory quality assessment of candidate gene panel testing for acute myeloid leukaemia: a joint ALLG / RCPAQAP initiative.
    Corboy G; Othman J; Lee L; Wei A; Ivey A; Blombery P; Agarwal R; Fong C; Brown A; Scott H; Grove C; Louw A; Enjeti A; Iland H; Paul C; Bohlander S; Kakadia P; Horan M; Stevenson W
    Pathology; 2021 Jun; 53(4):487-492. PubMed ID: 33272691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
    Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive Validation of Diagnostic Next-Generation Sequencing Panels for Acute Myeloid Leukemia Patients.
    Wagner U; Wong C; Camenisch U; Zimmermann K; Rechsteiner M; Valtcheva N; Theocharides A; Widmer CC; Manz MG; Moch H; Wild PJ; Balabanov S
    J Mol Diagn; 2022 Aug; 24(8):935-954. PubMed ID: 35718092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant allele frequencies do not correlate well with myeloblast counts in a clinically validated gene sequencing panel for routine acute myeloid leukemia workup.
    Toth LN; Green D; Peterson J; Deharvengt SJ; de Abreu FB; Loo EY
    Leuk Lymphoma; 2019 Oct; 60(10):2415-2422. PubMed ID: 30997856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.